STAT Plus: Supreme Court seems unlikely to overhaul popular drug industry legal strategy
J. SCOTT APPLEWHITE/AP
The Supreme Court heard oral arguments Monday in a case that could affect a legal strategy drug makers use to sidestep patient lawsuits.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario